Scinai Immunotherapeutics Statistics
Total Valuation
SCNI has a market cap or net worth of $3.80 million. The enterprise value is $21.55 million.
Important Dates
The next estimated earnings date is Tuesday, October 29, 2024, before market open.
| Earnings Date | Oct 29, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SCNI has 838,578 shares outstanding. The number of shares has increased by 96.30% in one year.
| Shares Outstanding | 838,578 |
| Shares Change (YoY) | +96.30% |
| Shares Change (QoQ) | +25.87% |
| Owned by Insiders (%) | 7.76% |
| Owned by Institutions (%) | 2.36% |
| Float | 730,725 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.16 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 75.87 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.19
| Current Ratio | 2.19 |
| Quick Ratio | 1.91 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -28.35% |
| Return on Capital (ROIC) | -31.73% |
| Revenue Per Employee | $9,161 |
| Profits Per Employee | -$119,484 |
| Employee Count | 31 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.78% in the last 52 weeks. The beta is 2.48, so SCNI's price volatility has been higher than the market average.
| Beta (5Y) | 2.48 |
| 52-Week Price Change | -53.78% |
| 50-Day Moving Average | 3.95 |
| 200-Day Moving Average | 4.66 |
| Relative Strength Index (RSI) | 64.80 |
| Average Volume (20 Days) | 34,640 |
Short Selling Information
| Short Interest | 10,066 |
| Short Previous Month | 6,212 |
| Short % of Shares Out | 1.20% |
| Short % of Float | 1.38% |
| Short Ratio (days to cover) | 0.36 |
Income Statement
In the last 12 months, SCNI had revenue of $284,000 and -$3.70 million in losses. Loss per share was -$7.24.
| Revenue | 284,000 |
| Gross Profit | -164,000 |
| Operating Income | -7.88M |
| Pretax Income | -19.70M |
| Net Income | -3.70M |
| EBITDA | -7.00M |
| EBIT | -7.88M |
| Loss Per Share | -$7.24 |
Full Income StatementBalance Sheet
The company has $3.08 million in cash and $20.82 million in debt, giving a net cash position of -$17.75 million or -$21.16 per share.
| Cash & Cash Equivalents | 3.08M |
| Total Debt | 20.82M |
| Net Cash | -17.75M |
| Net Cash Per Share | -$21.16 |
| Equity (Book Value) | -7.28M |
| Book Value Per Share | -8.70 |
| Working Capital | 1.99M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$6.67 million and capital expenditures -$262,000, giving a free cash flow of -$6.93 million.
| Operating Cash Flow | -6.67M |
| Capital Expenditures | -262,000 |
| Free Cash Flow | -6.93M |
| FCF Per Share | -$8.26 |
Full Cash Flow StatementMargins
| Gross Margin | -57.75% |
| Operating Margin | -2,774.65% |
| Pretax Margin | -1,304.23% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |